New hope for MS muscle stiffness: phase 3 drug trial launches
Symptom relief
Not yet recruiting
This study tests an extended-release tablet called arbaclofen to see if it safely reduces muscle stiffness (spasticity) in people with multiple sclerosis. About 442 adults aged 18 to 65 with MS-related spasticity will receive either the drug or a placebo. The goal is to measure c…
Phase: PHASE3 • Sponsor: RVL Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 15, 2026 19:07 UTC